Category: Drug Discovery
Drug Discovery market research reports by GlobalData
-
Retinitis Pigmentosa (RP) - Competitive Landscape
Retinitis Pigmentosa (RP) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in RP therapeutics. More than 1,000,000 diagnosed prevalent cases of RP are expected in 2024 in the 16 countries covered in GlobalData’s epidemiology ... Read More
-
Peripheral Artery Disease (PAD): Competitive Landscape
Peripheral Artery Disease (PAD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PAD therapeutics. More than 18,000,000 diagnosed prevalent cases of PAD are expected in 2024 in the 16 countries covered in GlobalData’s epid ... Read More
-
Fuchs Endothelial Corneal Dystrophy (FECD): Competitive Landscape
Fuchs Endothelial Corneal Dystrophy (FECD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in FECD therapeutics. More than 133,000,000 total prevalent cases of FECD are expected in 2024 in the 16 countries covered in GlobalD ... Read More
-
Augmented Reality in Healthcare - Thematic Research
Augmented Reality in Healthcare - Thematic Research Summary Augmented reality (AR) is a technology that allows the user to see the real world overlaid with digital data. According to GlobalData forecasts, the AR market will be worth $100 billion by 2030, up from $22 billion in 2022. Rather than enab ... Read More
-
Rare Disease Pipeline Analysis Landscape in 2023
Rare Disease Pipeline Analysis Landscape in 2023 Summary This report investigates the Rare Disease Pipeline Analysis Landscape in 2023 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via reg ... Read More
-
Premature Labor (PL) -Competitive Landscape
Premature Labor (PL) -Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PL therapeutics. More than 5,000,000 total prevalent cases of PL are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology foreca ... Read More
-
Hyperinsulinemia (HI) - Competitive Landscape
Hyperinsulinemia (HI) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in HI therapeutics. More than 1.07 billion prevalent cases of HI are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecas ... Read More
-
Acute Ischemic Stroke (AIS) - Competitive Landscape
Acute Ischemic Stroke (AIS) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AIS therapeutics. More than 90,000,000 diagnosed prevalent cases of AIS are anticipated in 2023 in the 16 countries covered in GlobalData’s epid ... Read More
-
Heart Failure in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032
Heart Failure in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Heart Failure (HF) market through 2032. Gl ... Read More
-
Dravet Syndrome (DS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Dravet Syndrome (DS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in DS therapeutics. More than 123,000 diagnosed prevalent cases of DS are anticipated in 2023 in ... Read More
-
Crohn's Disease in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032
Crohn's Disease in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032 Summary This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan, Canada) and provides an Excel-based forecast model for Crohn's Disease market through 2032. ... Read More
-
Artificial Intelligence in Pharma - Impact, Trends, Key Players and Top AI Drugs
Artificial Intelligence in Pharma - Impact, Trends, Key Players and Top AI Drugs Summary This report investigates the impacts and development of Artificial Intelligence within the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and mov ... Read More
-
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “Inflammatory Disease Markers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and K ... Read More
-
Batten Disease (BD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Batten Disease (BD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in BD therapeutics. Across the 16 major pharmaceutical markets, GlobalData estimates that there a ... Read More
-
Meningitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Meningitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Meningitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provi ... Read More
-
Myelodysplastic Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Myelodysplastic Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Myelodysplastic Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top ... Read More
-
Turner Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Turner Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Turner Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Up ... Read More
-
Idiopathic Hypersomnia (IH) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Idiopathic Hypersomnia (IH) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in IH therapeutics. More than 280,000 diagnosed prevalent cases of IH are anticipated in ... Read More
-
IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Berger's Disease therapeutics. More than 100,000 incident cases of Berger’s Dis ... Read More
-
Neurovascular Accessory Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Neurovascular Accessory Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Neurovascular Accessory Devices Pipeline Report including Stages of Development, Segmen ... Read More
-
Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in DLBCL therapeutics. More than 555,000 diagnosed prevalent cases of DLBCL are ... Read More
-
Cutaneous Squamous Cell Carcinoma (cSCC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Cutaneous Squamous Cell Carcinoma (cSCC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in cSCC therapeutics. More than 16 million diagnosed prevalent cases of DN a ... Read More
-
Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regu ... Read More
-
Dyslipidemia by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2032
Dyslipidemia by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Exc ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PTSD therapeutics. Scope GlobalData’s PTSD: Competitive Landscape combines d ... Read More
Research Assistance
